Perlium Amoxival 100 mg/g Premix for Medicated Feeding Stuff for Pigs

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: VMD (Veterinary Medicines Directorate)

Δραστική ουσία:

Amoxicillin

Διαθέσιμο από:

Ceva Animal Health Ltd

Φαρμακολογική κατηγορία (ATC):

QJ01CA04

INN (Διεθνής Όνομα):

Amoxicillin

Φαρμακοτεχνική μορφή:

Premix for medicated feeding stuff

Τρόπος διάθεσης:

POM-V - Prescription Only Medicine – Veterinarian

Θεραπευτική ομάδα:

Pigs

Θεραπευτική περιοχή:

Antimicrobial

Καθεστώς αδειοδότησης:

Expired

Ημερομηνία της άδειας:

2010-07-15

Αρχείο Π.Χ.Π.

Revised: October 2022
AN: 01677/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Perlium Amoxival 100 mg/g Premix for Medicated Feeding Stuff for Pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1g of premix contains :
Active substance
Amoxicillin (as Amoxicillin trihydrate)
100 mg
Excipients:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Premix for medicated feeding stuff.
Beige granulated powder
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In pigs: Preventive treatment of respiratory diseases due to
_Streptococcus suis_, limited to
reducing mortality. The presence of the disease in the herd should be
established before
the preventive treatment.
4.3
CONTRAINDICATIONS
Do not use in animals with serious kidney (accompanied by anuria and
oliguria) and/or
liver failure.
Do not used in animals with known hypersensitivity to betalactamins.
The use of the product is contraindicated when a resistance to
amoxicillin is known.
Do not use in the presence of β-lactamase producing bacteria.
Do not administer to rabbits, guinea-pigs, hamsters or gerbils.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Animals with reduced feed intake and/or disturbed general condition
have to be treated
parenterally.
Revised: October 2022
AN: 01677/2022
Page 2 of 5
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Animals with distinctive clinical signs of streptococcosis require
individual treatment.
Use of the veterinary medicinal product should be based on
susceptibility testing and take
into account official and local antimicrobial policies.
Inappropriate use of the veterinary medicinal product may increase the
prevalence of
bacteria resistant to amoxicillin.
This drug premix is intended for the preparation of solid drug feed
and cannot be used as
is; the concentration of incorporation of the drug premix in solid
feed must not be lower
than 5 kg/ton.
Special precautions to be taken by the